Press Releases
-
Univo IRB Launches First-of-Its-Kind Electronic IRB Submission Portal, OneVerse™
Univo IRB announced the launch of OneVerseTM — the industry’s first purpose-built, electronic platform that modernizes the IRB experience.
Jun 25, 2024
-
CatSci announces strategic acquisition of Reach Separations to offer end-to-end separation science support from discovery to manufacture, with the support of Keensight Capital
-
WCG and MRCT Center Form Task Force to Tackle Ethical Challenges in AI-Based Clinical Research
The task force will evaluate AI's use in various aspects of clinical trials, including protocol design, consent considerations, patient privacy and confidentiality, and participant recruitment. It will also evaluate AI when it is being studied as an investigational product for use in medical care.
Jun 25, 2024
-
Avallano Strengthens Leadership with New Chief Strategy Officer to Drive AI-Powered Clinical Research Innovation
Avallano has ann announced the appointment of Michael A. Ibara, PharmD., as Chief Strategy Officer (CSO).
Jun 25, 2024
-
Emmes partners with ILiAD Biotechnologies to Conduct Phase III Clinical Trials of BPZE1, the Leading Next-Generation Pertussis Vaccine
-
Argonaut Partner to Offer Accelerated End-to-End Drug Development Support for Biopharmaceutical Companies
Biopharma gains a seamless transition from drug discovery through drug product manufacturing
Jun 20, 2024
-
Bora Pharmaceuticals Expands North American Footprint with Agreement to Acquire First Sterile Manufacturing Facility
-
Cresset Successfully Achieves SOC 2 Compliance
-
Clinion and Clinevo’s Strategic Alliance for An Integrated eClinical Experience
AI-powered eClinical Platform, Clinion, announces strategic partnership with eClinical safety solutions provider, Clinevo.
Jun 19, 2024
-
CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations
CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024
Jun 16, 2024
-
ProPharma Recognized as a Top Outsourcing Partner
ProPharma, the world’s largest research consulting organization (RCO), a leading global provider of regulatory, clinical, and compliance services for the life sciences industry is pleased to announce it received a 2024 CRO Leadership Award.
Jun 12, 2024
-
Huateng Pharma to Exhibit at CPHI China 2024
-
MIB Agents’ Community of Families Has Awarded Over $1.9M in Grants to Research Pediatric Bone Cancer
Leading Pediatric Osteosarcoma Nonprofit to Present $350,000 to 5 Scientists on June 21 to Find Kinder Treatments for Patients
Jun 11, 2024
-
Onyx Scientific Aims for European Growth with New BD Hire
Small molecule specialists Onyx Scientific has made a significant new addition to its commercial team with the appointment of Courtnie Thomas Wilks as Business Development Manager for the UK and Europe.
Jun 12, 2024
-
CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT
CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT
Jun 11, 2024
-
CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’
CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’ CluePoints extends its use of AI/ML and continues to find smarter ways to manage clinical trials
Jun 11, 2024
-
Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy candidate AT-108 to clinical trial stage
Exothera has announced that Asgard Therapeutics has selected them to develop and scale-up a manufacturing process for the viral vector-based immunotherapy candidate AT-108, including development of analytical methods, GMP-grade material production, and aseptic filling.
Jun 10, 2024
-
CordenPharma & Certest: A Powerful Partnership Unleashing the Potential of Patented Ionizable Lipids in LNP Formulation
-
City University of New York Partners with Genestack to Enhance AI readiness of Life Science Data in the Bioconductor Program
Genestack has announced a collaboration with City University of New York (CUNY) to streamline data curation for the BioConductor program, a widely used open-source software project that provides tools for the analysis and comprehension of high-throughput genomic data.
Jun 5, 2024
-
FDA and CluePoints Sign New 3 Year Cooperative Research and Development Agreement to Assess Data Quality using Statistical Modelling and Machine Learning
FDA extends its use of CluePoints to include AI/ML within an automated system to assess data quality in multicenter clinical trials
Jun 4, 2024